Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization.

EBioMedicine | 2018

The epidermal growth factor receptor (EGFR) is known to play a critical role in non-small cell lung cancer (NSCLC). Constitutively active EGFR mutations, including in-frame deletion in exon 19 and L858R point mutation in exon 21, contribute about 90% of all EGFR-activating mutations in NSCLC. Although oral EGFR-tyrosine kinase inhibitors (TKIs), gefitinib and erlotinib, show dramatic clinical efficacy with significantly prolonged progression-free survival in patients harboring these EGFR-activating mutations, most of these patients will eventually develop acquired resistance. Researchers have recently named genomic instability as one of the hallmarks of cancer. Genomic instability usually involves a transient phase of polyploidization, in particular tetraploidization. Tetraploid cells can undergo asymmetric cell division or chromosome loss, leading to tumor heterogeneity and multidrug resistance. Therefore, identification of signaling pathways involved in tetraploidization is crucial in overcoming drug resistance. In our present study, we found that gefitinib could activate YAP-MKK3/6-p38 MAPK-STAT3 signaling and induce tetraploidization in gefitinib-resistance cells. Using p38 MAPK inhibitors, SB203580 and losmapimod, we could eliminate gefitinib-induced tetraploidization and overcome gefitinib-resistance. In addition, shRNA approach to knockdown p38α MAPK could prevent tetraploidy formation and showed significant inhibition of cancer cell growth. Finally, in an in vivo study, losmapimod could successfully overcome gefitinib resistance using an in-house established patient-derived xenograft (PDX) mouse model. Overall, these findings suggest that losmapimod could be a potential clinical agent to overcome gefitinib resistance in NSCLC.

Pubmed ID: 29398601 RIS Download

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


ATCC (tool)

RRID:SCR_001672

Global nonprofit biological resource center (BRC) and research organization that provides biological products, technical services and educational programs to private industry, government and academic organizations. Its mission is to acquire, authenticate, preserve, develop and distribute biological materials, information, technology, intellectual property and standards for the advancement and application of scientific knowledge. The primary purpose of ATCC is to use its resources and experience as a BRC to become the world leader in standard biological reference materials management, intellectual property resource management and translational research as applied to biomaterial development, standardization and certification. ATCC characterizes cell lines, bacteria, viruses, fungi and protozoa, as well as develops and evaluates assays and techniques for validating research resources and preserving and distributing biological materials to the public and private sector research communities.

View all literature mentions

Addgene (tool)

RRID:SCR_002037

Non-profit plasmid repository dedicated to helping scientists around the world share high-quality plasmids. Facilitates archiving and distributing DNA-based research reagents and associated data to scientists worldwide. Repository contains over 65,000 plasmids, including special collections on CRISPR, fluorescent proteins, and ready-to-use viral preparations. There is no cost for scientists to deposit plasmids, which saves time and money associated with shipping plasmids themselves. All plasmids are fully sequenced for validation and sequencing data is openly available. We handle the appropriate Material Transfer Agreements (MTA) with institutions, facilitating open exchange and offering intellectual property and liability protection for depositing scientists. Furthermore, we curate free educational resources for the scientific community including a blog, eBooks, video protocols, and detailed molecular biology resources.

View all literature mentions

Thermo Fisher Scientific (tool)

RRID:SCR_008452

Commercial vendor and service provider of laboratory reagents and antibodies. Supplier of scientific instrumentation, reagents and consumables, and software services.

View all literature mentions

Cell Signaling Technology (tool)

RRID:SCR_004431

Privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study cell signaling pathways that impact human health.

View all literature mentions

BD Biosciences (tool)

RRID:SCR_013311

An Antibody supplier

View all literature mentions

Image Pro Premier (tool)

RRID:SCR_016497

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on July 18,2023. Platform that delivers software tools to capture, process, measure, analyze and share images and data for scientific and industrial imaging community. Used for image-based data collection and analysis to increase accuracy and automate research, development, and quality processes.

View all literature mentions

NCI-H1975 (tool)

RRID:CVCL_1511

Cell line NCI-H1975 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MKK3 (D4C3) Rabbit mAb (antibody)

RRID:AB_11220233

This monoclonal targets MKK3 (D4C3) Rabbit mAb

View all literature mentions

MKK6 (D31D1) Rabbit mAb (antibody)

RRID:AB_11220227

This monoclonal targets MKK6 (D31D1) Rabbit mAb

View all literature mentions

YAP (D8H1X) XP Rabbit mAb (antibody)

RRID:AB_2650491

This recombinant monoclonal targets YAP

View all literature mentions

Phospho-YAP (Ser127) (D9W2I) Rabbit mAb (antibody)

RRID:AB_2650553

This recombinant monoclonal targets YAP

View all literature mentions

Stat3 (124H6) Mouse mAb (antibody)

RRID:AB_331757

This monoclonal targets Stat3

View all literature mentions

Phospho-Stat3 (Tyr705) (D3A7) XP Rabbit mAb (antibody)

RRID:AB_2491009

This monoclonal targets Phospho-Stat3 (Tyr705)

View all literature mentions

Cyclin D1 Antibody (antibody)

RRID:AB_2228523

This polyclonal targets Ccnd1

View all literature mentions

p38 MAPK Antibody (antibody)

RRID:AB_10694846

This polyclonal targets p38 MAPK

View all literature mentions

Phospho-p38 MAPK (Thr180/Tyr182) Antibody (antibody)

RRID:AB_331641

This polyclonal targets p38 MAPK, phospho (Thr180 / Tyr182)

View all literature mentions

goat anti-rabbit IgG-HRP (antibody)

RRID:AB_631746

This polyclonal targets goat anti-rabbit IgG-HRP

View all literature mentions

Ki-67 Polyclonal Antibody (antibody)

RRID:AB_10981523

This unknown targets Ki-67

View all literature mentions

BD CellQuest Pro (software resource)

RRID:SCR_014489

A software for acquiring and analyzing flow cytometry data. The user can create plots with elements like regions, gates, statistics, markers, and annotated text. The software can also be used for batch analysis or quality control of analysis. Results can be exported and saved.

View all literature mentions

HCC827 GR1 (cell line)

RRID:CVCL_V620

Cell line HCC827 GR1 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

HEK293T (cell line)

RRID:CVCL_0063

Cell line HEK293T is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

ZL55 (cell line)

RRID:CVCL_5908

Cell line ZL55 is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions

HCC827 (cell line)

RRID:CVCL_2063

Cell line HCC827 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions